A2ML1 and otitis media: novel variants, differential expression, and relevant pathways.

Area of Science:

• Genetics and Genomics
• Otolaryngology
• Molecular Biology

Background:

• Otitis media (middle ear infection) has a known genetic component, but the impact of rare genetic variants remains unclear.
• A previously identified A2ML1 gene duplication was associated with otitis media risk in specific populations.

Purpose of the Study:

• To investigate the role of rare genetic variants in A2ML1 as a risk factor for otitis media.
• To explore the relationship between A2ML1 variants, gene expression, and otitis media pathology.

Main Methods:

• Exome and Sanger sequencing were performed on DNA samples from diverse international families affected by otitis media.
• A2ML1 gene expression levels were analyzed in salivary RNA samples from both indigenous Filipino and US otitis media patients.
• Association analyses were conducted to link genetic variants and clinical phenotypes, including gingivitis.

Main Results:

• Sixteen novel, rare, and damaging A2ML1 variants were identified in otitis media patients.
• A2ML1 variants, including a known duplication and a novel splice variant, were independently associated with otitis media in indigenous Filipinos.
• Lower A2ML1 expression was observed in variant carriers, and differential expression of genes like RND3 was correlated with A2ML1 levels.

Conclusions:

• Rare A2ML1 variants contribute to otitis media etiology, potentially through impaired keratinocyte differentiation in the middle ear.
• Findings suggest A2ML1's role in otitis media pathogenesis and highlight the potential of ROCK inhibition as a therapeutic strategy.